Tesser J, Lin I, Shiff NJ, Chakravarty SD, et al. Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry. Clin Rheumatol 2022 Mar 21. pii: 10.1007/s10067-022-06116.
PMID: 35312895